Thank You Sites!
We are grateful for the work you do every day to improve human health.
Read More | Free eLearning
Upcoming Virtual Symposium
Gene Therapy Research in the Age of COVID-19: Study Startup Success for Infectious Disease, Oncology, and Rare Disease Research
Register Now
IRB Services
IBC Services
GxP/HRP Consulting Services
Canadian Review
Trust Advarra’s integrated solutions and collaborative approach to make your research altogether better.
Advarra® provides institutional review board (IRB), institutional biosafety committee (IBC) and GxP/HRP research compliance consulting services with unprecedented clarity.
Advarra recently acquired Forte, the market-leading provider of clinical technology solutions including OnCore. Learn more
Our Latest Updates
Discover What’s Happening at Advarra
Advarra Strengthens Leadership Team with the Announcement of Two New Key Executives
Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC), research technology solutions, and quality and compliance consulting services, today announced the addition of two senior executives:…
sIRB 101: An Introduction to Relying on an External IRB
Federal mandates for single IRB (sIRB) review of multisite research have ushered in a new era of sIRB oversight. Multisite research funded by NIH, HHS, and other agencies must now…
Safety Precautions for Laboratory Research With COVID-19 Specimens
The current global pandemic has brought biosafety to the spotlight. Biosafety practices must be customized to the proposed research as well as the existing facility and local regulatory requirements.